APIs per la ricerca e le impurità

iso-Gemfibrozil is a natural, synthetic drug product. It is an impurity standard for the pharmacopoeia and analytical standards for HPLC. iso-Gemfibrozil is metabolized in the liver to its active form, gemfibrozil. Impurities are not detected by HPLC and can be found in low levels in the API impurity standard. It has been used as a research and development candidate in clinical studies on atherosclerosis, hyperlipidemia, and diabetes mellitus.

Triphenylmethanol (TPM) is an inhibitor of the enzyme alcohol dehydrogenase. It is synthesized by reacting p-hydroxybenzoic acid with a hydroxyl group in the presence of trifluoroacetic acid and potassium carbonate. The reaction solution was then analyzed by x-ray crystallography, revealing the molecular structure of TPM. TPM binds to the metal ion in a hydroxyl group, preventing alcohol dehydrogenase from oxidizing ethanol to acetaldehyde. This mechanism also explains why TPM inhibits other enzymes that use this same metal ion cofactor such as carboxypeptidase A and aminopeptidase P, which are involved in protein synthesis and degradation.

Please enquire for more information about 13-Chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fluphenazine decanoate EP impurity E is an impurity found in Fluphenazine decanoate, a drug product. Fluphenazine decanoate EP impurity E is a natural metabolite of Fluphenazine decanoate that has been synthesized for use as an analytical reference standard and as an Impurity Standard for HPLC. The CAS number for Fluphenazine decanoate EP impurity E is

Desmethylmaprotiline hydrochloride is a drug product that is used in the manufacture of other drugs. It is an impurity standard for analytical purposes and an API impurity for pharmacopoeia. Desmethylmaprotiline hydrochloride is also a metabolite of maprotiline, which is used in the treatment of depression. The chemical structure of Desmethylmaprotiline hydrochloride can be found under CAS No. 92202-51-2 and it has been shown to be synthesized from maprotiline.

Salmeterol ep impurity A is an API impurity in the drug product 1-(RS)-1-[4-hydroxy-3-(hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol. It is a synthetic, natural, and pharmacopoeia impurity standard. The CAS number for this compound is 1798014-51-3. Salmeterol ep impurity A has a molecular weight of 255.9 g/mol and chemical formula of C24H30ClNO5.

N-Nitroso N-hydroxy cyclohexanamine is an analog of betamethasone and a potent inhibitor of kinases. It has been shown to have anticancer properties by inducing apoptosis in cancer cells. This compound is excreted in urine and has been studied extensively in Chinese populations for its potential as an anticancer agent. N-Nitroso N-hydroxy cyclohexanamine inhibits the activity of kinases, which are important enzymes involved in cell signaling pathways that regulate cell growth and division. This inhibition leads to the suppression of tumor growth and the induction of apoptosis in cancer cells. Additionally, this compound has been found to be a potent inhibitor of vitamin D receptor (VDR) and may play a role in regulating VDR-mediated gene expression.

Lansoprazole impurity H is a metabolite of lansoprazole, a proton pump inhibitor that inhibits the production of stomach acid. Lansoprazole impurity H is used in research and development as an analytical standard to measure lansoprazole concentrations in drug products. It is also used as an impurity standard for pharmacopoeia purposes. Lansoprazole impurity H is not known to be toxic, but it has not been evaluated for carcinogenicity or reproductive toxicity.

2-Methoxy-5-methyl-gamma-phenylbenzenepropanol is a synthetic compound that is used as an intermediate in the synthesis of coumarin derivatives. Reaction with sulfonating agents produces sulfones, and reaction with borohydride reagents produces boronates. The synthesis of 2-methoxy-5-methyl-gamma-phenylbenzenepropanol can be accomplished by the reduction of diphenyl ethers with lithium aluminum hydride or borohydride. The reduction can also be carried out using lanthanum oxide and potassium borohydride. The reaction proceeds smoothly at room temperature in nonpolar solvents.
2-Methoxy-5-methyl-gamma-phenylbenzenepropanol reacts with chloride to produce the corresponding chlorides, which are useful intermediates for the synthesis of tolterodine tartrate, a drug used to treat urinary inc

3-Descyano febuxostat ethyl ester is a synthetic, natural, and API impurity. 3-Descyano febuxostat ethyl ester is used as an analytical standard in drug development. It is also used as a custom synthesis, impurity standard and analytical reference material.

Tris(trifluoroacetoxy)iodine is an analog of iodine that has shown promise as an anticancer agent. It works by inhibiting kinase activity, which can disrupt the cell cycle and lead to apoptosis in cancer cells. Tris(trifluoroacetoxy)iodine has been found to be effective against a variety of human cancer cell lines, including those resistant to other anticancer agents. In addition, it has been shown to inhibit elastase activity and may have potential as an inhibitor of protein degradation in cancer cells. Overall, Tris(trifluoroacetoxy)iodine holds great potential as a new class of anticancer inhibitors with promising results for tumor treatment.

Please enquire for more information about Benzyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Nociceptin (1-7) is a drug product that is a natural, API impurity, and an impurity standard. It is used in research and development for the study of drug metabolism and pharmacopoeia for high purity standards in HPLC analysis. Nociceptin (1-7) is also synthesized as a synthetic compound with the CAS number 178249-42-8.

Descyclopropyl lenvatinib is a synthetic drug candidate that is being developed for the treatment of cancer. It is a metabolite of lenvatinib and has shown to have similar pharmacological activity, including inhibition of protein synthesis. Descyclopropyl lenvatinib also has been shown to inhibit the metabolism of other drugs, such as irinotecan, which may be due to its ability to inhibit cytochrome P450 enzymes.

Hydrocortisone EP Impurity H is an analytical standard that is used as an impurity in the production of hydrocortisone. It has been shown to have a purity level of 99.5% and can be used as a reference standard for HPLC analysis. Hydrocortisone EP Impurity H can also be used as a reference standard for drug product development, API impurities, and drug metabolite identification.

6,7-Dichloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ethyl ester is an impurity in the drug product, which is an HPLC standard. It has a natural origin and is not synthetically produced. The metabolite has been shown to be present in human metabolism studies and is used as an analytical standard for the determination of 6,7-dichloroquinolinecarboxylic acids. CAS No. 122224-58-2

9-Hydroxymethyl-10-carbamoylacridan is an active metabolite of carbamazepine. It is a potent competitive inhibitor of the enzyme acetylcholinesterase, which leads to increased levels of acetylcholine in the human brain and causes decreased seizure threshold. 9-Hydroxymethyl-10-carbamoylacridan can be found in wastewater and it has been detected in the water supply and in human serum. 9-Hydroxymethyl-10-carbamoylacridan is also present in human urine and can be detected by high performance liquid chromatography (HPLC). This compound has been shown to cause epileptic seizures in humans.

Please enquire for more information about Efavirenz-d5 including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Hydroxy azithromycin is an impurity of Azithromycin that is a metabolite of the drug. 4-Hydroxy azithromycin is a synthetic product, which has been synthesized for use as an analytical standard for HPLC and LC-MS/MS. It has also been used as a pharmacopoeia standard for testing antibiotic purity and quality. Metabolism studies have shown that 4-hydroxy azithromycin is not absorbed from the gastrointestinal tract, but is found in the urine and feces.

Ribosamine is a medicinal compound that has shown potential as an anticancer agent. It is a kinase inhibitor that targets specific proteins involved in cancer cell growth and survival. Ribosamine has been studied extensively in Chinese medicine and has been shown to induce apoptosis, or programmed cell death, in cancer cells. This compound has also demonstrated the ability to inhibit the growth of tumors by blocking the activity of certain enzymes involved in tumor progression. Ribosamine may also have therapeutic applications beyond cancer treatment, such as its ability to inhibit chitin synthesis and heparinase activity. Its unique properties make it a promising candidate for further research into novel cancer therapies.

6,7-Dehydrohyoscyamine (6,7DHHA) is a synthetic alkaloid that is produced by the dehydration of hyoscyamine. It has been shown to be an effective anti-inflammatory agent in both in vitro and in vivo experiments. 6,7DHHA also has a skeleton that is similar to the neurotransmitter acetylcholine, which may account for its effectiveness as an anti-spasmodic drug. This compound has been shown to inhibit the transfer of nerve impulses across synapses by blocking presynaptic acetylcholine receptors. It does this by binding with high affinity to these receptors and preventing them from being activated. 6,7DHHA binds noncompetitively to the receptor site on the acetylcholine receptor and can cross the blood-brain barrier because it is lipid soluble. The biosynthesis of 6,7DHHA starts with two molecules of L-phenylalanine condensed together with one molecule of L-

Please enquire for more information about Evixapodlin including the price, delivery time and more detailed product information at the technical inquiry form on this page